The aim of this present systematic review is to provide a comprehensive overview of the existing literature concerning the clinical applications of PET with TSPO ligands (i.e., TSPO PET) for glioma imaging, also trying to delineate the next steps for its implementation in clinical practice. This evidence concerns the gene TSPO and central nervous system cancer.